Page last updated: 2024-10-29

imipramine and Cancer of Head

imipramine has been researched along with Cancer of Head in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"Oral squamous cell carcinoma (OSCC) has limited treatment options."1.91Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways. ( Chang, PL; Chen, YT; Hsiao, HC; Hsieh, LL; Hsu, FT; Hsu, LC; Lin, CN; Lin, KH; Tu, HF; Wang, HY, 2023)
"Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion."1.43Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation. ( Arbiser, JL; Hsu, WH; Su, YH; Wang, CC; Yang, MH; Yang, WH, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hsu, LC1
Lin, CN1
Hsu, FT1
Chen, YT1
Chang, PL1
Hsieh, LL1
Wang, HY1
Lin, KH1
Hsiao, HC1
Tu, HF1
Yang, WH1
Su, YH1
Hsu, WH1
Wang, CC1
Arbiser, JL1
Yang, MH1

Other Studies

2 other studies available for imipramine and Cancer of Head

ArticleYear
Imipramine Suppresses Tumor Growth and Induces Apoptosis in Oral Squamous Cell Carcinoma: Targeting Multiple Processes and Signaling Pathways.
    Anticancer research, 2023, Volume: 43, Issue:9

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Head and Neck Neoplasms; Human

2023
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
    Oncogene, 2016, 05-05, Volume: 35, Issue:18

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Epithelial-Mesenchymal T

2016